Litcius/Paper detail

Characterization of on-target adverse events caused by TRK inhibitor therapy

D. Liu, James Flory, Andrew Lin, Michael Offin, Christina J. Falcon, Yonina R. Murciano‐Goroff, Ezra Y. Rosen, Robin Guo, Ellen M. Basu, Bob T. Li, James J. Harding, Gopa Iyer, Komal Jhaveri, Mrinal M. Gounder, Neerav Shukla, Stephen S. Roberts, Julia Glade Bender, Lauren A. Kaplanis, Alison M. Schram, David M. Hyman, Alexander Drilon

2020Annals of Oncology86 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTrk receptorAdverse effectOncologyInternal medicineNeurotrophinReceptorMelanoma and MAPK PathwaysPain Mechanisms and TreatmentsIon Channels and Receptors
Characterization of on-target adverse events caused by TRK inhibitor therapy | Litcius